Effect of Baseline Glycemic Level on Long-Term Cardiovascular Outcomes After Coronary Revascularization Therapy in Patients With Type 2 Diabetes Mellitus Treated With Hypoglycemic Agents
Effect of Baseline Glycemic Level on Long-Term Cardiovascular Outcomes After Coronary Revascularization Therapy in Patients With Type 2 Diabetes Mellitus Treated With Hypoglycemic Agents
复制标题
DOI：
10.1016/j.amjcard.2009.11.024
复制
发表时间：
2010-04-01
影响因子：
2.8
通讯作者：
Kimura, Takeshi
中科院分区：
文献类型：
--
作者：
Ehara, Natsuhiko;Morimoto, Takeshi;Kimura, Takeshi
本研究评估了接受降糖药物治疗并接受冠状动脉血管重建术的2型糖尿病患者术前糖化血红蛋白(HbA1c)水平与心血管预后的关系。我们对接受首次选择性冠状动脉血运重建术的日本患者进行了多中心登记。目前的研究包括3,571名患者，他们的HbA1c值在住院指数中是可用的。在3,571名患者中，2,067人没有糖尿病，1,504人患有2型糖尿病。在2型糖尿病患者中，202人的HbA1c水平=6%，但
The present study evaluated the association between preoperative hemoglobin A1c (HbA1c) levels and cardiovascular outcomes in patients with type 2 diabetes mellitus (DM) treated with hypoglycemic agents and undergoing coronary revascularization. We conducted a multicenter registry of Japanese patients undergoing first elective coronary revascularization. The present study included 3,571 patients whose HbA1c value at the index hospitalization was available. Of the 3,571 patients, 2,067 did not have DM and 1,504 had type 2 DM. Of the patients with type 2 DM, 202 had a HbA1c level of = 6% but